Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26725
Title: Severe speech impairment is a distinguishing feature of FOXP1-related disorder.
Austin Authors: Braden, Ruth O;Amor, David J;Fisher, Simon E;Mei, Cristina;Myers, Candace T;Mefford, Heather;Gill, Deepak;Srivastava, Siddharth;Swanson, Lindsay C;Goel, Himanshu;Scheffer, Ingrid E ;Morgan, Angela T
Affiliation: Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands
TY Nelson Department of Neurology, The Children's Hospital at Westmead, Sydney, NSW, Australia
Hunter Genetics, John Hunter Hospital, New Lambton Heights, NSW, Australia
Orygen and Centre for Youth Mental Health, University of Melbourne, Parkville, VIC, Australia
Austin Health
Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia
Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA, USA
Department of Neurology, Boston Children's Hospital, Boston, MA, USA
Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, the Netherlands
Murdoch Children's Research Institute, Parkville, VIC, Australia
Department of Audiology and Speech Pathology and Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia
The Royal Children's Hospital, Parkville, VIC, Australia
Victorian Clinical Genetics Service, Parkville, VIC, Australia
Issue Date: 9-Jun-2021
Date: 2021-06-09
Publication information: Developmental medicine and child neurology 2021; 63(12): 1417-1426
Abstract: To delineate the speech and language phenotype of a cohort of individuals with FOXP1-related disorder. We administered a standardized test battery to examine speech and oral motor function, receptive and expressive language, non-verbal cognition, and adaptive behaviour. Clinical history and cognitive assessments were analysed together with speech and language findings. Twenty-nine patients (17 females, 12 males; mean age 9y 6mo; median age 8y [range 2y 7mo-33y]; SD 6y 5mo) with pathogenic FOXP1 variants (14 truncating, three missense, three splice site, one in-frame deletion, eight cytogenic deletions; 28 out of 29 were de novo variants) were studied. All had atypical speech, with 21 being verbal and eight minimally verbal. All verbal patients had dysarthric and apraxic features, with phonological deficits in most (14 out of 16). Language scores were low overall. In the 21 individuals who carried truncating or splice site variants and small deletions, expressive abilities were relatively preserved compared with comprehension. FOXP1-related disorder is characterized by a complex speech and language phenotype with prominent dysarthria, broader motor planning and programming deficits, and linguistic-based phonological errors. Diagnosis of the speech phenotype associated with FOXP1-related dysfunction will inform early targeted therapy.
URI: https://ahro.austin.org.au/austinjspui/handle/1/26725
DOI: 10.1111/dmcn.14955
ORCID: 0000-0001-7730-1205
0000-0001-7191-8511
0000-0002-6765-8064
0000-0002-2311-2174
0000-0003-1147-7405
Journal: Developmental Medicine and Child Neurology
PubMed URL: 34109629
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

26
checked on Nov 2, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.